Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 276-

  Van Eijk, Y ^a   Boonen, A ^a   Schulpen, G ^a   Schrijnemaekers, V ^a   Fiolet, H ^a   Van Linden, Sj Der ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EXPERT NURSE; FEMALE; HEALTH CARE FACILITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SKIN ALLERGY; SPECIALIST NURSE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DAY CARE; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSE CLINICIANS; PATIENT SATISFACTION; RHEUMATOLOGY;

EID: 31144446599     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.036566     Document Type: Article

References (2)

1. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
2. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.